Trial Profile
Safety and efficacy of TRC150094 in treatment of cardio-metabolic risk in overweight/obese diabetic subjects with dyslipidemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Omzotirome (Primary)
- Indications Diabetes mellitus; Dyslipidaemias
- Focus Therapeutic Use
- Sponsors Torrent Pharmaceuticals
- 16 Apr 2013 New trial record